Northwest & Ethical Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
+46,398
| New | +$1.67M | 0.04% | 273 |
|
|
2024
Q4 | – | Sell |
-27,746
| Closed | -$785K | – | 533 |
|
|
2024
Q3 | $785K | Buy |
27,746
+1,913
| +7% | +$54.1K | 0.02% | 324 |
|
|
2024
Q2 | $681K | Sell |
25,833
-1,120
| -4% | -$29.5K | 0.02% | 323 |
|
|
2024
Q1 | $819K | Buy |
26,953
+21,148
| +364% | +$642K | 0.02% | 317 |
|
|
2023
Q4 | $163K | Buy |
+5,805
| New | +$163K | 0.01% | 360 |
|
|
2023
Q3 | – | Sell |
-18,170
| Closed | -$559K | – | 400 |
|
|
2023
Q2 | $559K | Buy |
+18,170
| New | +$559K | 0.02% | 323 |
|